Abstract
Protection against foot-and-mouth disease (FMD) using DNA technology has been documented for sheep and pigs but not for the highly susceptible species of cattle. Twenty-five Holstein Friesian cross-bred cattle were vaccinated twice, 21 days apart, with a DNA vaccine containing the capsid coding region (P1) along with the non-structural proteins 2A, 3C and 3D (pcDNA3.1/P1-2A3C3D) of O(1) Kaufbeuren alone or coated onto PLG (d,l-lactide-co-glycolide) microparticles. In some pcDNA3.1/P1-2A3C3D was also combined with an adjuvant plasmid expressing bovine granulocyte macrophage colony stimulating factor (GM-CSF). DNA vaccinations were administered intramuscularly with, or without, the use of electroporation and at 42 days post primary vaccination cattle received a protein boost of 146S FMD virus (FMDV) antigen and non-structural protein 3D. For comparison, four cattle were vaccinated with a conventional FMD vaccine and two more included as unvaccinated controls. Apart from those immunised with PLG microparticles all cattle were challenged with 10(5) TCID(50) cattle adapted O(1) Lausanne FMDV virus at day 93 post primary vaccination. All DNA vaccinated cattle regardless of regime developed good humoral and cell mediated responses pri...Continue Reading
References
Jan 1, 1992·Vaccine·F Brown
Mar 19, 1993·Science·J B UlmerA Friedman
Jun 3, 2000·Annual Review of Immunology·S GurunathanR A Seder
Dec 9, 2000·Virology·H T WongY Xie
Mar 17, 2001·Intervirology·K Cichutek
Mar 21, 2001·Vaccine·S van Drunen Littel-van den HurkL A Babiuk
Jun 28, 2001·Vaccine·L BenvenistiY Stram
May 30, 2002·Vaccine·Ho Tsun WongYong Xie
Aug 15, 2002·Journal of Virological Methods·Scott M ReidSoren Alexandersen
Jan 16, 2003·Virus Research·T R Doel
Jul 16, 2003·Journal of Comparative Pathology·S AlexandersenA J M Garland
Feb 15, 2005·Journal of the American Veterinary Medical Association·Ann H DavidsonM D Salman
Sep 13, 2005·Vaccine·Yanmin LiPaul V Barnett
Sep 29, 2005·Vaccine·P J BergmanJ D Wolchok
Oct 6, 2005·Vaccine·Satya ParidaDavid J Paton
Oct 26, 2005·Vaccine·S ParidaD J Paton
Nov 23, 2005·Vaccine·Virginia L MohlerJohn K House
Jun 7, 2006·Vaccine·E BrocchiK De Clercq
Sep 5, 2006·Vaccine·V NiborskiI Schwartz-Cornil
Apr 3, 2007·Journal of Virological Methods·Andrew E ShawDonald P King
Aug 22, 2007·Vaccine·N GorisK De Clercq
Mar 4, 2008·Vaccine·K E BrehmB Haas
Mar 7, 2008·Vaccine·Yanmin LiPaul V Barnett
Mar 18, 2008·Vaccine·V L FowlerP V Barnett
Aug 19, 2008·Vaccine·S van Drunen Littel-van den HurkJ V van den Hurk
May 20, 2011·Molecular Pharmaceutics·Ciaran LawlorSally-Ann Cryan
Oct 22, 2011·Veterinary Research·Miriam A WindsorBryan Charleston
Citations
Dec 12, 2012·Clinical and Vaccine Immunology : CVI·Sylvia van Drunen Littel-van den HurkDrew Hannaman
Oct 3, 2012·PloS One·Yooni OhSatya Parida
Jan 5, 2014·PloS One·Kai ZhaoYunfeng Wang
Sep 27, 2013·Expert Review of Vaccines·Luigi AurisicchioGennaro Ciliberto
Nov 5, 2016·The Veterinary Journal·J ImpellizeriD M Soden
Oct 17, 2017·Drug Delivery·Kai ZhaoZheng Jin
Sep 12, 2014·Journal of Virology·Anna LacastaFernando Rodríguez
Jan 19, 2019·Critical Reviews in Biotechnology·Ana Clara MignaquiAndrés Wigdorovitz
Sep 24, 2016·Oncotarget·Viswa Teja Colluru, Douglas G McNeel
Nov 18, 2016·Oncoimmunology·Viswa Teja ColluruDouglas G McNeel
Mar 20, 2019·Archives of Virology·Mohamed KamelHugo Castañeda Vazquez
Jun 3, 2020·Vaccines·Min Ja LeeJong-Hyeon Park
Nov 12, 2020·Frontiers in Veterinary Science·Ana Clara MignaquiAndrés Wigdorovitz
Mar 5, 2019·Current Medicinal Chemistry·Shuang YuKai Zhao
Dec 29, 2020·Frontiers in Bioengineering and Biotechnology·Teresia W MainaJodi L McGill
Dec 8, 2020·Frontiers in Bioengineering and Biotechnology·Sankar Renu, Gourapura J Renukaradhya
Feb 17, 2021·Research in Veterinary Science·Yunqi YangShiqi Sun
Mar 16, 2018·Current Opinion in Virology·Teresa de Los SantosLuis L Rodriguez
Nov 28, 2017·Molecular Pharmaceutics·Kai ZhaoYunfeng Wang